JIN Yan , TAO Dengshun , WANG Huishan , JIANG Hui , ZHAO Yang , HE Yuanchen , XU Shu , ZHANG Yong , YUE Fengjie
  • Department of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang, 110016, P. R. China;
TAO Dengshun, Email: taodengshun@hotmail.com
Ischemic mitral regurgitation; mitral valve surgery; coronary artery bypass grafting; left ventricular remodeling; echocardiography
10.7507/1007-4848.202203080
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Objective  To investigate surgical treatment and evaluate the curative effect in patients with moderate to severe ischemic mitral regurgitation (IMR). Methods  The clinical data of the patients with coronary heart disease complicated with moderate to severe IMR who agreed to receive surgical treatment from June 2014 to June 2019 in our hospital were analyzed retrospectively. The patients were divided into two groups: a coronary artery bypass grafting (CABG) group and a CABG+mitral valve surgery (MVS) group. The preoperative and postoperative clinical data between the two groups were compared. Results  Finally 105 patients were collected, including 75 males and 30 females, aged 40-79 (62.70±7.90) years. There were 34 patients in the CABG group, and 71 patients in the CABG+MVS group including 2 patients of mitral valvuloplasty and 29 patients of mitral valve replacement. Among the 105 patients, 5 died during the perioperative period and 2 died in 3 months after operation, all of whom were from the CABG+MVS group. There was no statistical difference in perioperative and postoperative 3-month mortality rate between the two groups (P=0.14). Eighty-seven patients were followed up in the medium and long term. There was no statistical difference in the degree of preoperative mitral insufficiency (MI) (P=0.59) and left atrium diameter (P=0.51) between the two groups, but the degree of postoperative MI in the CABG group was significantly higher than that in the CABG+MVS group (P<0.01). However, the left atrium diameter in the CABG group was significantly smaller than that in the CABG+MVS group (P<0.01). Paired analysis showed that systolic pulmonary artery pressure, left ventricular end-diastolic diameter, left ventricular end-systolic diameter, left ventricular ejection fraction and MI were significantly improved after operation (P<0.01); left atrium diameter was significantly improved after operation in the CABG group (P<0.01), but there was no statistical difference before and after operation in the CABG+MVS group (P=0.10). Conclusion  For patients with moderate to severe IMR, CABG with mitral valve treatment can improve left ventricular remodeling, but can not significantly improve left atrial remodeling. Whether performing mitral valve treatment during CABG should be cautious. CABG alone is a safe and effective scheme for elderly patients with poor physical condition and low life expectancy.

Citation： JIN Yan, TAO Dengshun, WANG Huishan, JIANG Hui, ZHAO Yang, HE Yuanchen, XU Shu, ZHANG Yong, YUE Fengjie. Mid-term effect of surgical treatment for moderate to severe ischemic mitral regurgitation. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2023, 30(12): 1714-1719. doi: 10.7507/1007-4848.202203080 Copy

  • Previous Article

    Analysis of the effect of totally thoracoscopic versus thoracoscopic-assisted minimally invasive small incision surgery in left atrial appendage clipping

  • Next Article

    One-stop carotid endarterectomy and off-pump coronary artery bypass grafting for patients with coronary artery disease and carotid artery stenosis